round button
Leave a message

Asia-Pacific Platelet Rich Plasma Market – Industry Trends and Forecast to 2029

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Asia-Pacific Platelet Rich Plasma Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Reports
  • Dec 2021
  • Asia-Pacific
  • 150 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Asia Pacific Platelet Rich Plasma Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2029
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
USD 8,733.08 Million
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Ycellbio Medical Co.
  • Cytomedix
  • Zimmer Biomet
  • Stryker
  • and others

Asia-Pacific Platelet Rich Plasma Market, By Type (Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Others), Origin (Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma), Application (Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others), End User (Hospitals and Clinics, Research Institutes, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific) Industry Trends and Forecast to 2029

Asia-Pacific Platelet Rich Plasma Market Market Analysis and Insights : Asia-Pacific Platelet Rich Plasma Market

Data Bridge Market Research analyses that the platelet rich plasma market to be grow at a CAGR of 13.25% in the forecast period of 2022-2029 and is expected to reach the USD 216.0 million by 2029.

Platelet rich plasma is endogenous plasma which is ideal for platelets and isolated from whole blood. Although PRP is a major component of platelets, other cellular components such as white blood cells (WBC) and peripheral stem cells may also be involved in the preparation. These are all biochemical components in drugs and are used at high levels of PRP. Therefore, PRP can help optimize the healing environment for bones and soft tissues.

The rise in the geriatric population and surge in the number of cosmetic surgery procedures are the major factors that will influence the growth of platelet rich plasma market. Furthermore, growing incidences of sport and orthopedic accidents, increasing awareness about PRP treatments and rise in the benefits of using traditional prefilled syringes are the major drivers that will enhance the growth of platelet rich plasma market. Moreover, technological advancement and emerging new markets will provide beneficial opportunities for the platelet rich plasma market growth.

However, high volatilization in the price of platelet-rich plasma therapy and favourable reimbursement policies in wound care devices are the factors that will obstruct the market growth. Also, problems with quality control and test results will challenge the platelet rich plasma market.  

This platelet rich plasma market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on platelet rich plasma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Platelet Rich Plasma Market Scope and Market Size

The platelet rich plasma market is segmented on the basis of type, origin, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • The platelet rich plasma market is segmented on the basis of type into pure platelet rich plasma, leukocyte-rich platelet rich plasma, leukocyte-rich fibrin and others.
  • On the basis of origin, the platelet rich plasma market is segmented into allogeneic platelet rich plasma, autologous platelet rich plasma and homologous platelet rich plasma.
  • On the basis of application, the platelet rich plasma market is segmented into cosmetic surgery and aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery and others. Others have been further sub-segmented into urology, cardiothoracic surgery, oral and maxillofacial surgery, periodontal surgery, otorhinolaryngology-head and neck surgery.

On the basis of end user, the platelet rich plasma market is segmented into hospitals, and clinics, research institutes and others.

Platelet Rich Plasma Market Country Level Analysis

The platelet rich plasma market is analysed and market size insights and trends are provided by country, type, origin, application and end user as referenced above.

The countries covered in the platelet rich plasma market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

Korea on the other hand is projected to exhibit the highest growth rate during the forecast period due to due to number of cosmetic surgeries to enhance facial features in this region.

The country section of the platelet rich plasma market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The platelet rich plasma market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for platelet rich plasma market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the platelet rich plasma market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Asia-Pacific Platelet Rich Plasma Market Share Analysis

The platelet rich plasma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to platelet rich plasma market.

Some of the major players operating in the platelet rich plasma market report are Ycellbio Medical Co., Ltd., Cytomedix, Inc. New, Zimmer Biomet, Stryker, Rocky Mountain Biologicals, Regen Lab SA, TERUMO BCT, INC., Glofinn Oy, Exatech, Inc., EmCyte Corporation, Medical Devices Business Services, Inc., ThermoGenesis Holdings, Inc., Octapharma Brasil Ltda, DR PRP USA LLC, Isto Biologics, Arthrex, Inc., Terumo Corporation, Cascade Medical, Grifols, S.A., Johnson & Johnson Private Limited, among others.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on Asia-Pacific Platelet Rich Plasma Market, By Type (Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Others), Origin (Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma), Application (Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others), End User (Hospitals and Clinics, Research Institutes, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific) Industry Trends and Forecast to 2029 .
The Asia Pacific Platelet Rich Plasma Market size was valued at USD 0.00 USD Million in 2022.
The Asia Pacific Platelet Rich Plasma Market is projected to grow at a CAGR of 13.25% during the forecast period of 2023 to 2029.
The major players operating in the market include Ycellbio Medical Co. , Cytomedix , Zimmer Biomet, Stryker, and others .
a